Arkolith/Insider Trading/SGP/Form 4

Vensana Capital I GP, LLC

10% OwnerSpyGlass Pharma, Inc. (SGP) · full profile →Form 4 · filed Feb 10, 2026
Net Buying
Open-Market Buys
$2.6M
Open-Market Sells
$0
Net Open-Market Flow
$2.6M
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)548K——2.2M
Feb 9, 2026Buy(P)165K$16.00$2.6M3.3M
Feb 9, 2026Conversion(C)359K——3.1M
Feb 9, 2026Conversion(C)1.7M——1.7M
Feb 9, 2026Conversion(C)548K——2.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)3.1M——0
Feb 9, 2026Conversion(C)2.1M——0
Feb 9, 2026Conversion(C)3.1M——0
Feb 9, 2026Conversion(C)9.7M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-045028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML